Your browser doesn't support javascript.
loading
Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effects.
Sung, Anthony D; Jauhari, Shekeab; Siamakpour-Reihani, Sharareh; Rao, Arati V; Staats, Janet; Chan, Cliburn; Meyer, Everett; Gadi, Vijayakrishna K; Nixon, Andrew B; Lyu, Jing; Xie, Jichun; Bohannon, Lauren; Li, Zhiguo; Hourigan, Christopher S; Dillon, Laura W; Wong, Hong Yuen; Shelby, Rebecca; Diehl, Louis; de Castro, Carlos; LeBlanc, Thomas; Brander, Danielle; Erba, Harry; Galal, Ahmed; Stefanovic, Alexandra; Chao, Nelson; Rizzieri, David A.
Afiliación
  • Sung AD; Duke University School of Medicine, Durham, North Carolina, USA.
  • Jauhari S; Duke University School of Medicine, Durham, North Carolina, USA.
  • Siamakpour-Reihani S; Duke University School of Medicine, Durham, North Carolina, USA.
  • Rao AV; Kite Pharma, San Francisco, California, USA.
  • Staats J; Duke University School of Medicine, Durham, North Carolina, USA.
  • Chan C; Duke University School of Medicine, Durham, North Carolina, USA.
  • Meyer E; Stanford University Medical School, Palo Alto, California, USA.
  • Gadi VK; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
  • Nixon AB; Duke University School of Medicine, Durham, North Carolina, USA.
  • Lyu J; Duke University School of Medicine, Durham, North Carolina, USA.
  • Xie J; Duke University School of Medicine, Durham, North Carolina, USA.
  • Bohannon L; Duke University School of Medicine, Durham, North Carolina, USA.
  • Li Z; Duke University School of Medicine, Durham, North Carolina, USA.
  • Hourigan CS; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung and Blood Institute, Bethesda, Maryland, USA.
  • Dillon LW; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung and Blood Institute, Bethesda, Maryland, USA.
  • Wong HY; Laboratory of Myeloid Malignancies, Hematology Branch, National Heart, Lung and Blood Institute, Bethesda, Maryland, USA.
  • Shelby R; Duke University School of Medicine, Durham, North Carolina, USA.
  • Diehl L; Duke University School of Medicine, Durham, North Carolina, USA.
  • de Castro C; Duke University School of Medicine, Durham, North Carolina, USA.
  • LeBlanc T; Duke University School of Medicine, Durham, North Carolina, USA.
  • Brander D; Duke University School of Medicine, Durham, North Carolina, USA.
  • Erba H; Duke University School of Medicine, Durham, North Carolina, USA.
  • Galal A; Duke University School of Medicine, Durham, North Carolina, USA.
  • Stefanovic A; Duke University School of Medicine, Durham, North Carolina, USA.
  • Chao N; Duke University School of Medicine, Durham, North Carolina, USA.
  • Rizzieri DA; Duke University School of Medicine, Durham, North Carolina, USA.
Am J Hematol ; 95(6): 662-671, 2020 06.
Article en En | MEDLINE | ID: mdl-32162718

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Idarrubicina / Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas / Citarabina / Quimioterapia de Inducción Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Hematol Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Idarrubicina / Leucemia Mieloide Aguda / Trasplante de Células Madre Hematopoyéticas / Citarabina / Quimioterapia de Inducción Tipo de estudio: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Hematol Año: 2020 Tipo del documento: Article